Cargando…
A pre‐investigational new drug study of lung spheroid cell therapy for treating pulmonary fibrosis
Idiopathic pulmonary fibrosis is a lethal interstitial lung disease with unknown etiology, no cure, and few treatment options. Herein, a therapy option is presented that makes use of a heterogeneous population of lung cells, including progenitor cells and supporting cells lines, cultured in adherent...
Autores principales: | Cores, Jhon, Dinh, Phuong‐Uyen C., Hensley, Taylor, Adler, Kenneth B., Lobo, Leonard J., Cheng, Ke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308638/ https://www.ncbi.nlm.nih.gov/pubmed/32304182 http://dx.doi.org/10.1002/sctm.19-0167 |
Ejemplares similares
-
Derivation of therapeutic lung spheroid cells from minimally invasive transbronchial pulmonary biopsies
por: Dinh, Phuong-Uyen C., et al.
Publicado: (2017) -
Safety and Efficacy of Allogeneic Lung Spheroid Cells in a Mismatched Rat Model of Pulmonary Fibrosis
por: Cores, Jhon, et al.
Publicado: (2017) -
Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis
por: Dinh, Phuong-Uyen C., et al.
Publicado: (2020) -
Novel Mesenchymal Stem Cell Spheroids with Enhanced Stem Cell Characteristics and Bone Regeneration Ability
por: Ohori-Morita, Yumi, et al.
Publicado: (2022) -
Effects of Matrix Metalloproteinases on the Performance of Platelet Fibrin Gel Spiked With Cardiac Stem Cells in Heart Repair
por: Shen, Deliang, et al.
Publicado: (2016)